|
1
|
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2013
|
12.73
|
|
2
|
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
|
Eur Heart J
|
2013
|
9.54
|
|
3
|
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
|
Eur Heart J
|
2013
|
6.17
|
|
4
|
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.
|
JAMA
|
2013
|
5.27
|
|
5
|
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
|
Eur Heart J
|
2013
|
5.23
|
|
6
|
Recent national trends in readmission rates after heart failure hospitalization.
|
Circ Heart Fail
|
2009
|
3.95
|
|
7
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur Heart J
|
2016
|
3.83
|
|
8
|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
|
Eur J Heart Fail
|
2016
|
2.91
|
|
9
|
Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions.
|
BMJ
|
2013
|
2.36
|
|
10
|
Hospital volume and 30-day mortality for three common medical conditions.
|
N Engl J Med
|
2010
|
2.20
|
|
11
|
Improved prognosis after using mild hypothermia to treat cardiorespiratory arrest due to a cardiac cause: comparison with a control group.
|
Rev Esp Cardiol
|
2009
|
2.13
|
|
12
|
MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado) study. General findings.
|
Rev Esp Cardiol
|
2008
|
2.09
|
|
13
|
[Underutilization of acetylsalicylic acid of cardiovascular prevention in patients with diabetes mellitus].
|
Med Clin (Barc)
|
2004
|
1.70
|
|
14
|
Chest pain in the emergency department: incidence, clinical characteristics and risk stratification.
|
Rev Esp Cardiol
|
2008
|
1.56
|
|
15
|
[2002 Update of the Guidelines of the Spanish Society of Cardiology for Unstable Angina/Without ST-Segment Elevation Myocardial Infarction].
|
Rev Esp Cardiol
|
2002
|
1.44
|
|
16
|
[Type of treatment and short-term outcome in elderly patients with acute myocardial infarction admitted to hospitals with a primary coronary angioplasty facility. The TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry].
|
Rev Esp Cardiol
|
2005
|
1.43
|
|
17
|
Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation.
|
Thromb Haemost
|
2013
|
1.43
|
|
18
|
[Short-and long-term cost-effectiveness analysis of adding clopidogrel to standard therapy in acute coronary syndrome patients in Spain].
|
Rev Esp Cardiol
|
2005
|
1.41
|
|
19
|
Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification.
|
Circ J
|
2015
|
1.40
|
|
20
|
[Characteristics and mortality following primary percutaneous coronary intervention for acute myocardial infarction in Spain. Results from the TRIANA 1 (TRatamiento del Infarto Agudo de miocardio eN Ancianos) Registry].
|
Rev Esp Cardiol
|
2005
|
1.36
|
|
21
|
Variation in recovery: Role of gender on outcomes of young AMI patients (VIRGO) study design.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.26
|
|
22
|
The relationship between systolic blood pressure on admission and mortality in older patients with heart failure.
|
Eur J Heart Fail
|
2010
|
1.12
|
|
23
|
[A new risk score for patients with a normal or non-diagnostic ECG admitted to a chest pain unit].
|
Rev Esp Cardiol
|
2005
|
1.09
|
|
24
|
Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus.
|
Am J Cardiol
|
2009
|
1.07
|
|
25
|
NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies.
|
PLoS One
|
2011
|
1.04
|
|
26
|
Influence of reperfusion therapy on prognosis in patients aged >or=89 years with acute myocardial infarction.
|
Am J Cardiol
|
2005
|
0.96
|
|
27
|
Patterns of use and effectiveness of early invasive strategy in non-ST-segment elevation acute coronary syndromes: an assessment by propensity score.
|
Am Heart J
|
2008
|
0.96
|
|
28
|
Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases.
|
Heart
|
2011
|
0.93
|
|
29
|
Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS).
|
Am Heart J
|
2011
|
0.92
|
|
30
|
"Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?".
|
Am Heart J
|
2010
|
0.92
|
|
31
|
[Applicability of a new definition of myocardial infarction and the opinion of Spanish cardiologists].
|
Rev Esp Cardiol
|
2003
|
0.91
|
|
32
|
Patient registries of acute coronary syndrome: assessing or biasing the clinical real world data?
|
Circ Cardiovasc Qual Outcomes
|
2009
|
0.88
|
|
33
|
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups.
|
Heart
|
2006
|
0.88
|
|
34
|
Prognosis and management of patients with acute coronary syndrome and polyvascular disease.
|
Rev Esp Cardiol
|
2009
|
0.88
|
|
35
|
FRAIL-HF, a study to evaluate the clinical complexity of heart failure in nondependent older patients: rationale, methods and baseline characteristics.
|
Clin Cardiol
|
2014
|
0.86
|
|
36
|
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
|
Rev Esp Cardiol (Engl Ed)
|
2016
|
0.85
|
|
37
|
Differences in medical treatment of chronic coronary heart disease patients according to medical specialities.
|
Cardiovasc Ther
|
2009
|
0.83
|
|
38
|
A review of international pharmacoeconomic models assessing the use of aspirin in primary prevention.
|
J Med Econ
|
2010
|
0.82
|
|
39
|
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
|
2016
|
0.81
|
|
40
|
Disposition of emergency department patients diagnosed with acute heart failure: an international emergency medicine perspective.
|
Eur J Emerg Med
|
2017
|
0.79
|
|
41
|
Prediction of 30-day mortality in older patients with a first acute myocardial infarction.
|
Cardiology
|
2009
|
0.79
|
|
42
|
Acute coronary syndromes: considerations for improved acceptance and implementation of management guidelines.
|
Expert Rev Cardiovasc Ther
|
2012
|
0.79
|
|
43
|
Influence of age on gender differences in the management of acute inferior or posterior myocardial infarction.
|
Chest
|
2005
|
0.78
|
|
44
|
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes.
|
Eur Heart J
|
2006
|
0.77
|
|
45
|
Control of risk factors in and treatment of patients with coronary heart disease: the TRECE study.
|
Rev Esp Cardiol
|
2009
|
0.76
|
|
46
|
[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].
|
Kardiol Pol
|
2016
|
0.76
|
|
47
|
Insulin receptor substrate-1 expression is increased in circulating leukocytes of patients with acute coronary syndrome.
|
ISRN Cardiol
|
2011
|
0.75
|
|
48
|
Are available electrocardiographic methods accurate enough to diagnose ventricular tachycardia in the emergency department?
|
Acad Emerg Med
|
2013
|
0.75
|
|
49
|
Perceived Stress After Acute Myocardial Infarction: A Comparison Between Young and Middle-Aged Women Versus Men.
|
Psychosom Med
|
2016
|
0.75
|
|
50
|
Fatal retroperitoneal haemorrhage associated with enoxaparin and impaired renal function.
|
Int J Cardiol
|
2005
|
0.75
|
|
51
|
[The value of an intervention for improving secondary prevention in patients undergoing cardiac surgery].
|
Rev Esp Cardiol
|
2008
|
0.75
|
|
52
|
[Not Available].
|
Rev Esp Cardiol
|
2009
|
0.75
|
|
53
|
Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
|
Rev Esp Cardiol (Engl Ed)
|
2016
|
0.75
|
|
54
|
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2017
|
0.75
|
|
55
|
Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
|
Am Heart J
|
2013
|
0.75
|
|
56
|
[Ischemic heart disease: 2005 update].
|
Rev Esp Cardiol
|
2006
|
0.75
|
|
57
|
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
|
Eur Heart J
|
2017
|
0.75
|
|
58
|
Differential effect of β-blockers for heart rate control in coronary artery disease.
|
Clin Cardiol
|
2011
|
0.75
|
|
59
|
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
|
Eur J Cardiothorac Surg
|
2017
|
0.75
|
|
60
|
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
|
Eur J Vasc Endovasc Surg
|
2017
|
0.75
|
|
61
|
Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes.
|
Int J Clin Pharm
|
2014
|
0.75
|
|
62
|
Impact of frailty and functional status on outcomes in elderly patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: rationale and design of the IFFANIAM study.
|
Clin Cardiol
|
2013
|
0.75
|
|
63
|
[Intermediate coronary care units: rationale, infrastructure, equipment, and referral criteria].
|
Rev Esp Cardiol
|
2007
|
0.75
|
|
64
|
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].
|
Eur J Cardiothorac Surg
|
2017
|
0.75
|
|
65
|
Sudden Cardiac Death in Professional Soccer Players.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
66
|
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
|
Rev Esp Cardiol (Engl Ed)
|
2017
|
0.75
|
|
67
|
[Ischemic heart disease: 2006 update].
|
Rev Esp Cardiol
|
2007
|
0.75
|
|
68
|
Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
|
Pharmacoepidemiol Drug Saf
|
2012
|
0.75
|
|
69
|
Treatment and outcomes of severe cardiac disease with surgical indication in very old patients.
|
Int J Cardiol
|
2006
|
0.75
|